Division of Nuclear Medicine

Research

Are You a Patient?

  • Chondrogiannis S, Marzola MC, Grassetto G, Zorzi A, Milan E, Rampin L, Rubello D, Colletti PM. 18F-FDG PET/CT lung ‘focalities’ without coregistered CT findings: an interpretative clinical dilemma.Nucl Med Commun. 2015 Apr;36(4):334-9.
    Manca G, Volterrani D, Mazzarri S, Chondrogiannis S, Giammarile F, Rubello D, Colletti PM. Sentinel lymph node biopsy of oral/oropharyngeal squamous cell carcinoma: techniques, indications, advantages, and accuracy.Clin Nucl Med. 2015 May;40(5):401-4.
    Ceci F, Castellucci P, Graziani T, Schiavina R, Chondrogiannis S, Bonfiglioli R, Costa S, Virgolini IJ, Rubello D, Fanti S, Colletti PM. 11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer.Clin Nucl Med. 2015 May;40(5):e265-70.
    Chiaravalloti A, Rubello D, Chondrogiannis S, Giammarile F, Colletti PM, Schillaci O. Low-dose CT and contrast-medium CT in hybrid PET/CT systems for oncologic patients.Nucl Med Commun. 2015 Apr 2.
    [Epub ahead of print].
    Rubello D, Colletti PM, Cook GJ. What is the role of radionuclide sentinel lymph node biopsy and dissection in papillary thyroid cancer? Nucl Med Commun. 2015 Oct;36(10):969-70.
    Bluemel C, Rubello D, Colletti PM, de Bree R, Herrmann K. Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges. Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1469-80.
    Maffione AM, Marzola MC, Capirci C, Colletti PM, Rubello D. Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2015 Jun;204(6):1261-8.
    Duce V, Manca G, Mazzarri S, Lorenzetti F, Colletti PM, Rubello D, Volterrani D. Sentinel Node Mapping in Melanoma of the Back: SPECT/CT Helps Discriminate “True” and “False” in-Transit Lymph Nodes. Clin Nucl Med. 2015 Jun 6. [Epub ahead of print].
    Boschin IM, Pelizzo MR, Giammarile F, Rubello D, Colletti PM. Lymphoscintigraphy in Differentiated Thyroid Cancer. Clin Nucl Med. 2015 Jul;40(7):e343-50.
    Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, Audisio RA, Zoras O, Lassmann M, Chakera AH, Uren R, Chondrogiannis S, Colletti PM, Rubello D. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1750-66. Epub 2015 Jul 25.
    Pelizzo MR, Pennelli G, Zane M, Galuppini F, Colletti PM, Merante Boschin I, Rubello D. Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics.Biomed Pharmacother. 2015 Aug;74:9-16. Epub 2015 Jul 13.
    Rubello D, Gordien P, Morliere C, Guyot M, Bordenave L, Colletti PM, Hindié E. Variability of Hepatic 18F-FDG Uptake at Interim PET in Patients With Hodgkin Lymphoma. Clin Nucl Med. 2015 Aug;40(8):e405-10.
    Faulkner A, Mehta P, Romero M, Colletti PM. Coordinating ABNM Eligibility Within a Modified 48-Month Diagnostic Radiology Program. Clin Nucl Med. 2015 Aug;40(8):658-9. PMID: 26091337
    Doroudinia A, Colletti PM. Bone Mineral Measurements. Clin Nucl Med. 2015 Aug;40(8):647-57; quiz p 653-7.
    Sulzbacher L, Klinger M, Scheurecker C, Wacha M, Shamiyeh A, Malek M, Colletti PM, Rubello D, Gabriel M. Clinical Usefulness of a Novel Freehand 3D Imaging Device for Radio-Guided Intraoperative Sentinel Lymph Node Detection in Malignant Melanoma. Clin Nucl Med. 2015 Sep;40(9):e436-40.
    Mehta P, Wassef H, Colletti PM. Prior CT May Improve Diagnostic Confidence in Myocardial Perfusion Imaging. Clin Nucl Med 2015;40: e480–e483.
    Azad GK, Taylor B, Rubello D, Colletti PM, Goh V, Cook GJ. Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview. Clin Nucl Med. 2015 Sep 22. [Epub ahead of print].
    Pelizzo MR, Torresan F, Da Roit A, Merante Boschin I, Chondrogiannis S, Rampin L, Colletti PM, Vinjamury S, Perkins AJ, Rubello D. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits. Rev Esp Med Nucl Imagen Mol. 2015 Sep 23. [Epub ahead of print] English, Spanish.
    Manca G, Rubello D, Tardelli E, Giammarile F, Mazzarri S, Boni G, Chondrogiannis S, Marzola MC, Chiacchio S, Ghilli M, Roncella M, Volterrani D, Colletti PM. Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies. Clin Nucl Med. 2015 Oct 8. [Epub ahead of print].
    Lopci E, Grassi I, Rubello D, Colletti PM, Cambioli S, Gamboni A, Salvi F, Cicoria G, Lodi F, Dazzi C, Mattioli S, Fanti S. Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT. Clin Nucl Med. 2015 Oct 8. [Epub ahead of print].
    Azad GK, Taylor B, Rubello D, Colletti PM, Goh V, Cook GJ. Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview. Clin Nucl Med 2015;00: 00–00
    Duce V, Manca G, Mazzarri S, Lorenzetti F, Colletti PM, Rubello D, Volterrani D. Sentinel Node Mapping in Melanoma of the Back: SPECT/CT Helps Discriminate” True” and” False” in-Transit Lymph Nodes. Clin Nucl Med 2015;00: 00–00.
    Limouris GS, Poulantzas V, Trompoukis N, Karfis I, Chondrogiannis S, Triantafyllou N, Gennimata V, Moulopoulou LE, Patsouris E, Nikou G, Michalaki V, Fragulidis G, Paphiti M, McCready RV, Colletti PM, Cook GJ, Rubello D. Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases. Clin Nucl Med. 2015 Dec 15. [Epub ahead of print].
    Stelzmueller I, Huber H, Wunn R, Hodolic M, Mandl M, Lamprecht B, Schinko H, Fellner F, Skanjeti A, Giammarile F, Colletti PM, Rubello D, Gabriel M. 18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis. Clin Nucl Med. 2015 Dec 22. [Epub ahead of print]
    Manca G, Vanzi E, Rubello D, Giammarile F, Grassetto G, Wong KK, Perkins AC, Colletti PM, Volterrani D. 18F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications. Eur J Nucl Med Mol Imaging. 2016 Jan 19. [Epub ahead of print].
    Wong KK, Miller BS, Viglianti BL, Dwamena BA, Gauger PG, Cook GJ, Colletti PM, Rubello D, Gross MD. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review. Clin Nucl Med. 2016 Jan 28. [Epub ahead of print].
    Jadvar H, Ballas L, Quinn DI. Chapter 19.6: Treatment of bone metastases: Radiopharmaceuticals. In: Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management, Dicker AP, Kelly WK, Trabulsi EJ, Zaorsky NG (eds.), Demos Medical Publishing, New York, NY; pp. 375-384; 2015. (ISBN: 9781936287598).
    Jadvar H, Conti PS. PET/CT and PET/MRI in kidney tumors and bladder cancer. In: Clinical Molecular
    Anatomic Imaging: PET, PET/CT, and SPECT/CT, Von Schulthess GK (ed.), 2nd ed. Lippincott Williams &Wilkins, Philadelphia, PA; 2015.
    Jadvar H. Prognostic utility of PET in prostate cancer. In: PET Clinic: PET/CT and Patient Outcomes in Oncology, Part I, Subramaniam R (ed.), Elsevier, Inc., New York, NY; 2014.
    Jadvar H, Shulkin B. Chapter 17: Other Neoplasms, In: Clinical Nuclear Medicine in Pediatrics, Mansi L, Lopci E, Cuccurullo V, Chiti A (eds.), Springer, Inc., New York, NY; pp. 337-347; 2016. (ISBN 978-3-31921370-5).
    Jadvar H. Imaging cellular proliferation in prostate cancer with positron emission tomography. Asia Oceania J Nucl Med Biol 3(2):72-76; 2015. (Invited Review Article).
    Jadvar H, Subramaniam RM, Berman CG, Boada F, Colletti PM, Guimaraes AR, McConathy J, Meltzer CC, Noto RB, Packard AB, Rohren EM, Oates ME. American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MRI: Brain. J Nucl Med April 2015; 56:642-645.
    Jadvar H, Chala S, Quinn D, Conti PS. One-year post-approval clinical experience with Radium-223 dichloride in patients with metastatic castrate-resistant prostate cancer. Cancer Biotherm Radiopharm Jun 2015;30(5):195-9.
    Fahey F, Zukotynski K, Jadvar H, Capala J. With input from the Organizing Committee, Contributors, and Participants of the 2nd NCI/SNMMI Workshop on Targeted Radionuclide Therapy: Proceedings of the 2nd NCI-SNMMI Workshop on Targeted Radionuclide Therapy, J Nucl Med Jul 2015;56(7):1119-1129.
    Jadvar H. PSMA PET in Prostate Cancer. J Nucl Med Aug 2015;56(8):1131-1132.
    Jadvar H, Chen K, Ukimura O. Targeted Prostate Gland Biopsy with Combined TRUS, mpMRI and 18F-FMAU PET-CT. Clin Nucl Med Aug 2015;40(8):e426-8.
    Jadvar H. Positron emission tomography in prostate cancer: summary of systematic reviews and meta-analysis. Tomography Sept 2015;1(1):18-22.
    Jadvar H. Positron emission tomography in imaging evaluation of staging, restaging treatment response, and prognosis in prostate cancer. Abdom Radiol 2016. (Invited Review Article) (In Press).
    Wassef, H. Brain Perfusion Imaging with SPECT and PET. In Saremi, F. (Ed.), Perfusion Imaging in Clinical Practice: A Multimodality Approach to Tissue Perfusion Analysis. Philadelphia, PA : Lippincott Williams & Wilkins. Exact publication date: May 22,2015.
    Wassef H, Ho, L. Hepatobiliary, Pancreas, Adrenal, Melanoma and GIST. Conti P., Kaushik, A. (Eds.) PET-CT: A Case-Based Approach. New York, NY: Springer.
    Wassef, H, Colletti, P. PET-CT in Head-neck Malignancies: The Implications for Personalized Clinical Practice. PET Clinics. Submitted Jan, 2016. (in-press).

    • Colletti PC.  Fever of Unknown Origin-Multimodality Imaging.  Correlative Imaging Council, SNMMI 2015 Annual Meeting, Baltimore, MD.  June 6-10, 2015.
    • Colletti PC.  Treatment with 131I. Viva Las Vegas, Las Vegas, NV.  July 18-19, 2015.
    • Colletti PC.  MRI 101.  Viva Las Vegas, Las Vegas, NV.  July 18-19, 2015.
    • Colletti PC.  CT and MRI Cases.  WRSNMMI Annual Meeting, Monterey, CA.  October 22-25, 2015.
    • Colletti PC.  Lymphoscintigraphy 2015.  Pacific Southwest Technologist Meeting, Duarte, CA.  November 21, 2015.
    • Colletti PC.  Appropriate Use Criteria for FDG PET/CT in the Re-Staging of Neoplastic Disease. SNMMI Midwinter Meeting, Orlando, FL.  January 28-31, 2016.
    • Jadvar H.  1.Treatment response evaluation with imaging. 2. Theranostics in neuroendocrine tumors. 3. Alpha therapy of metastatic prostate cancer. 4. Impact and cost-effectiveness of PET in oncology. RAS6071 Strengthening Radionuclide Therapy for High Impact Cancer Treatment Strategy in Member States of the Regional Cooperative Agreement.  Manila, Philippines.  April 2015.
    • Jadvar H. 1. Outcome prediction in cancer with PET: Prognostic utility of PET in Prostate Cancer. 2. CTN-Outreach Cmte Joint Session: Advances in Prostate Cancer: Imaging, Diagnosis, and Management — Imaging Metabolic Pathways with FDG and C-11 Acetate in Prostate Cancer. SNMMI 61st Annual Meeting, Baltimore, MD. June 6-10, 2015.
    • Doroudinia A, Desai B, Yoon J, Jadvar H. Treatment Response Assessment in Metastatic Prostate Cancer with 18F-NaF PET/CT.  Proc SNMMI 61st Annual Meeting, Baltimore, MD.  Jun 6-10, 2015.
    • Jadvar H, Desai B, Ji L, Groshen S, Mills J, Murray R, Quinn DI. Comparison of RECIST 1.0, PERCIST 1.0 and PCWG2 Treatment Response Criteria in Metastatic Castrate-Sensitive Prostate Cancer.  Proc SNMMI 61st Annual Meeting, Baltimore, MD.  Jun 6-10, 2015.
    • Jadvar H, Desai B, Ji L, Groshen S, Mills J, Murray R, Quinn DI. Prediction of hormonal resistance in metastatic prostate cancer with FDG PET/CT. Proc SNMMI 61st Annual Meeting, Baltimore, MD.  Jun 6-10, 2015.
    • Jadvar H. 1. Clinical impact of PET/Ct in oncology. 2. PET/CT in prostate cancer: diagnosis and prognosis. 3. Monitoring of therapy response by PET/CT in oncology. Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico. August 2015.
    • advar H. Molecular Imaging and Targeted Radionuclide Therapy of Prostate Cancer. Department of Radiology Grand Rounds, University of Utah, Salt Lake City, UT.  August 2015.
    • Jadvar H. Treatment response assessment in oncology: time to evolve? Pasadena, CA. LARS 2015.
    • Jadvar H. Hepatobiliary Scintigraphy in Abdominal Pain. Development of Appropriate Use Criteria for Hepatobiliary Scintigraphy of Abdominal Pain;European Association of Nuclear Medicine (EANM)/SNMMI Joint Symposium. Hamburg, Germany, October 2015.
    • Jadvar H. Alpha particle therapy in prostate cancer. SNMMI Southeastern Chapter Annual Meeting, Charleston, SC. October 2-4, 2015.
    • Jadvar H. Alpha particle therapy of prostate cancer. SNMMI Pacific Northwest Chapter Meeting, Portland, OR.  October 22-25, 2015.
    • Jadvar H.  PET-CT Imaging in Breast Cancer.  PET-CT in Cancer Management . International Conference on Clinical PET-CT and Molecular Imaging. IPET 2015, Vienna, Austria. October 2015.
    • Jadvar H. 1. F18-FDG-PET/CT thyroid, 2. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas (Brazilian National Cancer Institute). 1. Role of F18-FDG-PET/CT in the diagnosis of endocarditis, 2. Myocardial Viabilty: State of the Art, 3. Radioprotection in Cardiovascular Nuclear Medicine (Universidade Federal Fluminense). 1. F18-FDG-PET/CT thyroid, 2. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas, 3. Round Table with Brazilian Nuclear Medicine Board of Directors (Brazilian Nuclear Medicine Congress). Brazilian Nuclear Medicine Congress; Brazilian National Cancer Institute; Universidade Federal Fluminense, Rio de Janiro, Brazil. October 2015
    • Jadvar H.  Plenary Lecture: Molecular imaging and radionuclide therapy of prostate cancer. Asia Oceanic Congress of Nuclear Medicine and Biology (AOCNMB), Jeju, South Korea. October 2015.
    • Jadvar H. 1. Opening Plenary Lecture 1: Current role of molecular imaging as a translational tool. 2. Plenary Lecture 2: Molecular imaging and radionuclide therapy of prostate cancer. Association of Latin American Societies of Biology and Nuclear Medicine (ALASBIMN), Punta del Este, Uruguay. November 2015.
    • Jadvar H. Molecular imaging and radionuclide therapy of prostate cancer. Japanese Society of Nuclear Medicine 55th Annual Scientific Meeting, Tokyo, Japan. November 2015.
    • Jadvar H. Prostate Cancer Choline PET Imaging and Other PET Tracers; II. Radiological Society of North America (RSNA) 101st Annual Meeting, Chicago, IL.  November 29 – December 4, 2015.
    • Yoon J, Ballas L, Desai B, Ji L, Groshen S, Jadvar H. PSA and PSA kinetics in predicting 18F-NaF PET/CT positivity for first bone metastases in patients with biochemical recurrence after radical prostatectomy.  RSNA 101st Scientific Assembly & Annual Meeting, Chicago, IL. Nov-Dec 2015.
    • Jadvar H. State and Emerging Science of Nuclear Medicine. SNMMI 2016 Mid Winter Meeting, Orlando, FL. January 28-31, 2016.
    • Jadvar H. Molecular Imaging and Endoradiotherapy in Prostate Cancer. University of California, Irvine, CA. February 2016.
    • Jadvar H.Molecular imaging and radionuclide therapy of prostate cancer. SNMMI 61st Annual Southwest Chapter Meeting, Dallas, TX. April 15-17, 2016.